GB0807094D0 - 4,4-dimethylpiperidine-2, 6-dione derivatives for use in the treatment of hypertension - Google Patents

4,4-dimethylpiperidine-2, 6-dione derivatives for use in the treatment of hypertension

Info

Publication number
GB0807094D0
GB0807094D0 GBGB0807094.8A GB0807094A GB0807094D0 GB 0807094 D0 GB0807094 D0 GB 0807094D0 GB 0807094 A GB0807094 A GB 0807094A GB 0807094 D0 GB0807094 D0 GB 0807094D0
Authority
GB
United Kingdom
Prior art keywords
dimethylpiperidine
hypertension
treatment
dione derivatives
dione
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0807094.8A
Other versions
GB2445888B (en
GB2445888A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prestwick Pharmaceuticals Inc
Original Assignee
Prestwick Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prestwick Pharmaceuticals Inc filed Critical Prestwick Pharmaceuticals Inc
Publication of GB0807094D0 publication Critical patent/GB0807094D0/en
Publication of GB2445888A publication Critical patent/GB2445888A/en
Application granted granted Critical
Publication of GB2445888B publication Critical patent/GB2445888B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GB0807094A 2005-09-14 2008-04-18 Treatment of hypertension Expired - Fee Related GB2445888B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0518763.8A GB0518763D0 (en) 2005-09-14 2005-09-14 Treatment of hypertension
PCT/GB2006/003379 WO2007031737A1 (en) 2005-09-14 2006-09-13 4,4-dimethylpiperidine-2,6-dione derivatives for use in the treatment of hypertension

Publications (3)

Publication Number Publication Date
GB0807094D0 true GB0807094D0 (en) 2008-05-21
GB2445888A GB2445888A (en) 2008-07-23
GB2445888B GB2445888B (en) 2010-01-06

Family

ID=35221487

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0518763.8A Ceased GB0518763D0 (en) 2005-09-14 2005-09-14 Treatment of hypertension
GB0807094A Expired - Fee Related GB2445888B (en) 2005-09-14 2008-04-18 Treatment of hypertension

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0518763.8A Ceased GB0518763D0 (en) 2005-09-14 2005-09-14 Treatment of hypertension

Country Status (2)

Country Link
GB (2) GB0518763D0 (en)
WO (1) WO2007031737A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458537A (en) * 1973-12-15 1976-12-15
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
GB2379216A (en) * 2001-08-28 2003-03-05 Maurice Ward Gittos Piperidin-2,6-dione salts useful for the treatment of stress-related affective disorders
GB0219639D0 (en) * 2002-08-22 2002-10-02 Prestwick Scient Capital Inc Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders

Also Published As

Publication number Publication date
GB2445888B (en) 2010-01-06
WO2007031737A1 (en) 2007-03-22
GB0518763D0 (en) 2005-10-19
GB2445888A (en) 2008-07-23

Similar Documents

Publication Publication Date Title
IL185242A0 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
PT1922309E (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
ZA200705040B (en) 2,4 (4,6) pyrimidine derivatives
IL190135A0 (en) Process for the preparation of pyrimidinedione derivatives
IL180680A0 (en) Piperazine derivatives useful for the treatment of gastrointestinal disorders
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
ME01219B (en) Alfa-aminoamide derivatives useful in the treatment of addictive disorders
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
AP2006003659A0 (en) Azabenzofuran substituted thioureas, inhibitors ofviral replication
IL198519A (en) 7-methoxy- 1, 2, 3, 11- tetrahydro-5, 11-diaza-benzo[a] trindene-4,6-dione and derivatives thereof for use as radio-sensitizing agents for the treatment of cancer
PL378587A1 (en) Methods of (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazole and/or its salts
IL178261A0 (en) Use of 5,10-methylene tetrahydrofolate for the treatment of cancer
HK1110025A1 (en) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
IL188390A0 (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
EP1750698A4 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
PL374461A1 (en) Method for obtaining the derivatives of 13,14-dihydro-pgf
PL1879585T3 (en) Use of pyrimidylamimobenzamide derivatives for the treatment of systemic mastocytosis
PL1890695T3 (en) Use of 2,5-disubstituted thiazol-4-one derivatives in drugs
PL2366393T3 (en) Roflumilast for the treatment of pulmonary hypertension
EP1786433A4 (en) Betulinol derivatives as anti-hiv agents
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
IL190334A0 (en) Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20090827 AND 20090902

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20150913